Literature DB >> 8721405

Application of saliva for drug monitoring. An in vivo model for transmembrane transport.

R Haeckel1, P Hänecke.   

Abstract

The determination of salivary drug concentrations is one of the major domains for the application of saliva in laboratory medicine. Its usefulness, however, has been criticized for many drugs because of the variability of the saliva/plasma concentration ratio (saliva/plasma ratio). Considering saliva as a model for transmembrane transport, drugs can be divided into 4 groups. The first group is characterized by a saliva/plasma ratio less than 1.0. In extreme cases a drug with negligible transport is either not detectable in saliva or is found in very low concentrations which are hard to measure or difficult to interpret. A second group leads to saliva/plasma ratios which are approximately constant and about 1.0 under most of the conditions studied. This group is ideal for monitoring salivary drug concentrations. A third group is sufficiently transferred into saliva, but the saliva/plasma ratio varies under different conditions. The reason for this variation is that the transport is influenced by several factors including an active transport mechanism. The varying influence of these factors on the saliva/plasma ratio largely depends on the physico-chemical characteristics of the particular substance. In a fourth group very high saliva/plasma ratios are observed primarily due to the degree of ionization of weak bases. A representative of each group is presented with its saliva/plasma ratio and its physico-chemical properties: ceftazidim, ethanol, digoxin and prilocain. In all cases the salivary concentration probably reflects the intracellular concentration in target tissues. All examples confirm saliva as an ideal in vivo model for the study of transmembrane transport in the human organism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721405

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  22 in total

Review 1.  Salivary biomarkers: toward future clinical and diagnostic utilities.

Authors:  Janice M Yoshizawa; Christopher A Schafer; Jason J Schafer; James J Farrell; Bruce J Paster; David T W Wong
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 2.  Clinical validity of saliva and novel technology for cancer detection.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Fang Wei; Shannon Liu Rao; Jinseok Kim; Heebum Shin; Jordan Cheng; Michael Tu; David T W Wong; Yong Kim
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 3.  Current developments in salivary diagnostics.

Authors:  Craig S Miller; Joseph D Foley; Alison L Bailey; Charles L Campell; Roger L Humphries; Nicolaos Christodoulides; Pierre N Floriano; Glennon Simmons; Bryon Bhagwandin; James W Jacobson; Spencer W Redding; Jeffrey L Ebersole; John T McDevitt
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 4.  Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors:  Mwlod Ghareeb; Fatemeh Akhlaghi
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

5.  Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.

Authors:  Riet Dams; Robin E Choo; Willy E Lambert; Hendree Jones; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2006-09-27       Impact factor: 4.492

Review 6.  Saliva: an emerging biofluid for early detection of diseases.

Authors:  Yu-Hsiang Lee; David T Wong
Journal:  Am J Dent       Date:  2009-08       Impact factor: 1.522

7.  Digoxin concentration in saliva and plasma in infants, children, and adolescents with heart disease.

Authors:  Eli Zalzstein; Nili Zucker; Matityhau Lifshitz
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

8.  Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals.

Authors:  Nawei Zhang; Zhenyu Zhang; Shan Feng; Qingtao Wang; Daniel Malamud; Haiteng Deng
Journal:  Anal Chim Acta       Date:  2013-03-01       Impact factor: 6.558

9.  Common Salivary Protein 1 in Serum of Diabetes Patients.

Authors:  HongTao Wang; Seok-Mo Heo; Heung Yong Jin; Eui Yul Choi; Sang Wook Oh
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

10.  Salivary glucose levels and oral candidal carriage in Type 2 diabetics.

Authors:  Amritaksha Bhattacharyya; Shaleen Chandra; Anil Singh; Vineet Raj; Bhavana Gupta
Journal:  J Oral Biol Craniofac Res       Date:  2018-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.